Changes in serum virus-specific IgM/IgG antibody in asymptomatic and discharged patients with reoccurring positive COVID-19 nucleic acid test (RPNAT)

被引:11
作者
Liu, Junli [1 ]
Lian, Rui [2 ]
Zhang, Guochao [3 ]
Hou, Baojun [4 ]
Wang, Chuming [1 ]
Dong, Jian [5 ]
Yang, Liu [1 ]
Wang, Jianglan [1 ]
Dai, Shangming [1 ]
Chen, Libo [6 ]
Zhang, Guoqiang [2 ]
Lu, Xin [7 ]
Ye, Ting [8 ]
机构
[1] Union Jiangbei Hosp, Lab Dept, Wuhan, Peoples R China
[2] China Japan Friendship Hosp, Emergency Dept, Beijing, Peoples R China
[3] China Japan Friendship Hosp, Gen Surg Dept, Beijing, Peoples R China
[4] Union Jiangbei Hosp, Endocrinol Dept, Wuhan, Peoples R China
[5] Union Jiangbei Hosp, Resp Dept, Wuhan, Peoples R China
[6] Union Jiangbei Hosp, Emergency Dept, Wuhan, Peoples R China
[7] Friendship Hosp, Rheumatol & Immunol Dept, Beijing, Peoples R China
[8] Wuhan First Biosci Co Ltd, Wuhan, Peoples R China
关键词
COVID-19; IgM; IgG antibody; asymptomatic patient; discharged patient with reoccurring positive nucleic acid test (RPNAT); WUHAN; INFECTIONS; PNEUMONIA;
D O I
10.1080/07853890.2020.1811887
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Studies have demonstrated the diagnostic efficiency of antibody testing in COVID-19 infection. There is limited data on the IgM/IgG changes in asymptomatic and discharged patients with reoccurring positive nucleic acid test (RPNAT). This study aims to investigate these IgM/IgG changes. Methods There were 111 patients with positive nucleic acid test (NAT) and 40 suspected patients enrolled in the study. The serum SARS-CoV-2 specific IgM/IgG antibody levels were retrospectively analysed with the disease progress in asymptomatic and RPNAT patients. Results The best overall performance was found by combining the IgM, IgG, and CT; 95.1% sensitivity and 75% specificity. This was tested in 111 RT-PCR positive cases. The median IgM and IgG levels were lower in the asymptomatic group compared to the symptomatic group (p < .01). Among 15 RPNAT cases, the IgM levels of the RPNAT group at the time of discharge (IgM2.79, IQR: 0.95-5.37) and retest (IgM 2.35, IQR: 0.88-8.65) were significantly higher than those of the non-reoccurring positive nucleic acid test group (Non-RPNAT) (IgM on discharge: 0.59, IQR: 0.33-1.22, IgG on retest: 0.92, IQR: 0.51-1.58). Conclusion Serum SARS-CoV-2 specific IgM/IgG antibody levels remained at a low level during hospitalisation for asymptomatic patients. Elevated IgM levels may have implications in the identification of RPNAT patients before discharge.Key messages This study determined the IgM/IgG changes in asymptomatic and RPNAT patients. The rate of serum SARS-CoV-2 specific IgM/IgG antibody levels increase in the asymptomatic group was lower than in the symptomatic group during hospitalisation. The IgM level did not decrease significantly at discharge in the RPNAT patients, and was higher than that of the Non-RPNAT group on discharge. These results highlight the importance of timely monitoring of IgM levels to identify RPNAT patients before discharge.
引用
收藏
页码:34 / 42
页数:9
相关论文
共 33 条
[1]  
[Anonymous], 2020, NEW CORONAVIRUS PNEU, V5th
[2]  
[Anonymous], 2020, NEW ENGL J MED, DOI [DOI 10.1056/NEJMoa2001316, DOI 10.1056/NEJMOA2001316]
[3]   CRISPR-Cas14 is now part of the artillery for gene editing and molecular diagnostic [J].
Aquino-Jarquin, Guillermo .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 18 :428-431
[4]   A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster [J].
Chan, Jasper Fuk-Woo ;
Yuan, Shuofeng ;
Kok, Kin-Hang ;
To, Kelvin Kai-Wang ;
Chu, Hin ;
Yang, Jin ;
Xing, Fanfan ;
Liu, Jieling ;
Yip, Cyril Chik-Yan ;
Poon, Rosana Wing-Shan ;
Tsoi, Hoi-Wah ;
Lo, Simon Kam-Fai ;
Chan, Kwok-Hung ;
Poon, Vincent Kwok-Man ;
Chan, Wan-Mui ;
Ip, Jonathan Daniel ;
Cai, Jian-Piao ;
Cheng, Vincent Chi-Chung ;
Chen, Honglin ;
Hui, Christopher Kim-Ming ;
Yuen, Kwok-Yung .
LANCET, 2020, 395 (10223) :514-523
[5]   Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia [J].
Chu, Daniel K. W. ;
Pan, Yang ;
Cheng, Samuel M. S. ;
Hui, Kenrie P. Y. ;
Krishnan, Pavithra ;
Liu, Yingzhi ;
Ng, Daisy Y. M. ;
Wan, Carrie K. C. ;
Yang, Peng ;
Wang, Quanyi ;
Peiris, Malik ;
Poon, Leo L. M. .
CLINICAL CHEMISTRY, 2020, 66 (04) :549-555
[6]  
Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1148/radiol.2020200230, 10.1007/s00330-019-06574-1]
[7]   Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR (Publication with Expression of Concern) [J].
Corman, Victor M. ;
Landt, Olfert ;
Kaiser, Marco ;
Molenkamp, Richard ;
Meijer, Adam ;
Chu, Daniel K. W. ;
Bleicker, Tobias ;
Bruenink, Sebastian ;
Schneider, Julia ;
Schmidt, Marie Luisa ;
Mulders, Daphne G. J. C. ;
Haagmans, Bart L. ;
van der Veer, Bas ;
van den Brink, Sharon ;
Wijsman, Lisa ;
Goderski, Gabriel ;
Romette, Jean-Louis ;
Ellis, Joanna ;
Zambon, Maria ;
Peiris, Malik ;
Goossens, Herman ;
Reusken, Chantal ;
Koopmans, Marion P. G. ;
Drosten, Christian .
EUROSURVEILLANCE, 2020, 25 (03) :23-30
[8]   Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village [J].
Day, Michael .
BMJ-BRITISH MEDICAL JOURNAL, 2020, 368 :m1165
[9]   Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) [J].
Guo, Li ;
Ren, Lili ;
Yang, Siyuan ;
Xiao, Meng ;
Chang, De ;
Yang, Fan ;
Dela Cruz, Charles S. ;
Wang, Yingying ;
Wu, Chao ;
Xiao, Yan ;
Zhang, Lulu ;
Han, Lianlian ;
Dang, Shengyuan ;
Xu, Yan ;
Yang, Qi-Wen ;
Xu, Sheng-Yong ;
Zhu, Hua-Dong ;
Xu, Ying-Chun ;
Jin, Qi ;
Sharma, Lokesh ;
Wang, Linghang ;
Wang, Jianwei .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) :778-785
[10]   Novel Coronavirus Disease 2019 (COVID-19) Pneumonia Progression Course in 17 Discharged Patients: Comparison of Clinical and Thin-Section Computed Tomography Features During Recovery [J].
Han, Xiaoyu ;
Cao, Yukun ;
Jiang, Nanchuan ;
Chen, Yan ;
Alwalid, Osamah ;
Zhang, Xin ;
Gu, Jin ;
Dai, Meng ;
Liu, Jie ;
Zhu, Wanyue ;
Zheng, Chuansheng ;
Shi, Heshui .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) :723-731